Active Stock under Estimate Umbrella: American International Group (NYSE:AIG), The Progressive (NYSE:PGR)

Shares of American International Group, Inc. (NYSE:AIG) [Trend Analysis] runs in leading trade, it moving down -0.69% to traded at $63.78. The firm has price volatility of 1.02% for a week and 1.33% for a month. Its beta stands at 1.23 times. Lets us look over what analysts have to say about performance of the AIG. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $1.15 as compared to the next year Q1 current trend of $1.23. While on annual basis the current EPS estimates trend for FY 2017 came in for $6.04 as compared to three months ago $3.79.

The stock prices target chart showed high target of 74.00 kept by analysts at WSJ while the average price target was for 69.06 as compared to current price of 63.78. Somehow, the stock managed to gain BUY ratings by 14 analysts in current tenure as 2 analysts having overweight ratings, 6 recommend as HOLD. Overall, the consensus ratings were for Overweight by the pool of analysts. Narrow down four to firm performance, its weekly performance was -0.34% and monthly performance was -0.53%. The stock price of AIG is moving down from its 20 days moving average with -0.71% and isolated negatively from 50 days moving average with -2.22%.

The Progressive Corporation (NYSE:PGR) [Trend Analysis] luring active investment momentum, shares a loss -1.05% to $39.41. Finally to see some strong financial remarks by WSJ over PGR performance. Out of the pool of analysts 5 gave their BUY ratings on the stock in previous month as 5 analysts having BUY in current month. The stock was ranked as Underweight by 1 analyst while 3 analysts gave SELL rank. Majority ranked Hold from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $0.63 while one month ago this estimate trend was for $0.53. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $2.38 and for the one month was for $1.70 as compared to three months ago was for $1.51. Whereas, PGR received highest price target of 45.00 and low target of 30.01. The stock price target chart showed average price target of 37.60 as compared to current price of 39.41.

The total volume of 2.08 Million shares held in the session was surprisingly higher than its average volume of 2831.22 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -18.10%, and looking further price to next year’s EPS is 10.22%. While take a short look on price to sales ratio, that was 0.97 and price to earnings ratio of 22.34 attracting passive investors.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *